Volume 31, Issue 1 pp. 19-22
Original Article

Detection of high-risk human papillomavirus (HPV) DNA by Hybrid Capture II in women referred due to atypical glandular cells in the primary screening

Eliane R.Z.M. Oliveira

Eliane R.Z.M. Oliveira

Department of Obstetrics and Gynecology Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil

Search for more papers by this author
Sophie F.M. Derchain

Corresponding Author

Sophie F.M. Derchain

Department of Obstetrics and Gynecology Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil

Rua Antônio Hossri, 629 - Cidade Universitária, 13083-370 - Campinas - SP, BrazilSearch for more papers by this author
Silvia H. Rabelo-Santos

Silvia H. Rabelo-Santos

Department of Obstetrics and Gynecology Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil

Faculty of Pharmacy, Universidade Federal de Goiás (UFG), Goiânia, GO, Brazil

Search for more papers by this author
Maria Cristina A. Westin

Maria Cristina A. Westin

Department of Obstetrics and Gynecology Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil

Search for more papers by this author
Luiz Carlos Zeferino

Luiz Carlos Zeferino

Department of Obstetrics and Gynecology Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil

Search for more papers by this author
Elisabete A. Campos

Elisabete A. Campos

Department of Obstetrics and Gynecology Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil

Search for more papers by this author
Kari J. Syrjanen

Kari J. Syrjanen

Cytopathology Unit, Laboratory of Epidemiology, National Institute of Health (ISS), Rome, Italy

Search for more papers by this author
First published: 28 June 2004
Citations: 19

Abstract

We assessed the detection of high-risk human papillomavirus DNA (HPV-DNA) in women examined by a second Pap smear due to atypical glandular cells (AGC) detected in their screening Pap smear. In 91 women included in the study, a second Pap smear was taken and HPV-DNA test was performed using Hybrid Capture II (HC II). The second Pap smear showed no abnormalities in 28 (31%) cases, ACG in 17 (19%) cases, and high-grade squamous intraepithelial lesions (HSIL) or worse in 24 (26%). HC II test was positive in 36% of the cases. Considering the second Pap smear diagnosis, HPV-DNA was detected in 87% of the women with HSIL, 100% of women with in situ adenocarcinoma, and only in 11% of the women with no abnormalities. The use of the second Pap smear combined with HPV-DNA may improve the management of women with AGC in the primary screening. Diagn. Cytopathol. 2004;31:19–22. © 2004 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.